Stock Comparison
BSX vs SYK
Boston Scientific Corp and Stryker Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$65.74B
$127.55B
P/E (TTM)
18.5
38.5
Forward P/E
13.2
22.2
Price/Sales
3.2
5.1
Price/Book
2.5
5.6
EV/EBITDA
13.7
21.6
Dividend Yield
—
1.09%
Profitability
Net Margin
17.30%
13.20%
Operating Margin
20.60%
17.80%
Return on Equity
14.70%
15.20%
Return on Assets
6.07%
7.72%
Growth (YoY)
Revenue Growth
11.60%
2.60%
Earnings Growth
100.00%
14.20%
Price & Risk
Beta
0.6
0.8
52-Week High
$109.50
$401.86
52-Week Low
$43.89
$281.00
Analyst Target
$75.00
$386.80
Compare BSX and SYK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.